Menu
GeneBe

16-56885363-C-T

Variant summary

Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PM2PM5PP3PP5_Very_Strong

The NM_001126108.2(SLC12A3):c.1924C>T(p.Arg642Cys) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.0000556 in 1,546,188 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R642G) has been classified as Likely pathogenic.

Frequency

Genomes: 𝑓 0.000053 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000056 ( 0 hom. )

Consequence

SLC12A3
NM_001126108.2 missense, splice_region

Scores

11
4
1
Splicing: ADA: 0.9855
2

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:5

Conservation

PhyloP100: 5.51
Variant links:
Genes affected
SLC12A3 (HGNC:10912): (solute carrier family 12 member 3) This gene encodes a renal thiazide-sensitive sodium-chloride cotransporter that is important for electrolyte homeostasis. This cotransporter mediates sodium and chloride reabsorption in the distal convoluted tubule. Mutations in this gene cause Gitelman syndrome, a disease similar to Bartter's syndrome, that is characterized by hypokalemic alkalosis combined with hypomagnesemia, low urinary calcium, and increased renin activity associated with normal blood pressure. This cotransporter is the target for thiazide diuretics that are used for treating high blood pressure. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 13 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr16-56885363-C-G is described in ClinVar as [Likely_pathogenic]. Clinvar id is 397523.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
PP3
Splicing scoreres supports a deletorius effect: Scorers claiming Pathogenic: dbscSNV1_ADA, dbscSNV1_RF. No scorers claiming Uncertain. Scorers claiming Benign: max_spliceai.
PP5
Variant 16-56885363-C-T is Pathogenic according to our data. Variant chr16-56885363-C-T is described in ClinVar as [Pathogenic]. Clinvar id is 944812.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SLC12A3NM_001126108.2 linkuse as main transcriptc.1924C>T p.Arg642Cys missense_variant, splice_region_variant 15/26 ENST00000563236.6
SLC12A3NM_000339.3 linkuse as main transcriptc.1924C>T p.Arg642Cys missense_variant, splice_region_variant 15/26
SLC12A3NM_001126107.2 linkuse as main transcriptc.1921C>T p.Arg641Cys missense_variant, splice_region_variant 15/26
SLC12A3NM_001410896.1 linkuse as main transcriptc.1921C>T p.Arg641Cys missense_variant, splice_region_variant 15/26

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SLC12A3ENST00000563236.6 linkuse as main transcriptc.1924C>T p.Arg642Cys missense_variant, splice_region_variant 15/261 NM_001126108.2 A1P55017-1
SLC12A3ENST00000438926.6 linkuse as main transcriptc.1924C>T p.Arg642Cys missense_variant, splice_region_variant 15/261 A1P55017-2
SLC12A3ENST00000566786.5 linkuse as main transcriptc.1921C>T p.Arg641Cys missense_variant, splice_region_variant 15/261 P4P55017-3
SLC12A3ENST00000262502.5 linkuse as main transcriptc.1921C>T p.Arg641Cys missense_variant, splice_region_variant 15/265 A1

Frequencies

GnomAD3 genomes
AF:
0.0000526
AC:
8
AN:
152180
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000126
AC:
20
AN:
158898
Hom.:
0
AF XY:
0.0000837
AC XY:
7
AN XY:
83662
show subpopulations
Gnomad AFR exome
AF:
0.000111
Gnomad AMR exome
AF:
0.000120
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000694
Gnomad SAS exome
AF:
0.000219
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000483
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000560
AC:
78
AN:
1393890
Hom.:
0
Cov.:
29
AF XY:
0.0000509
AC XY:
35
AN XY:
688230
show subpopulations
Gnomad4 AFR exome
AF:
0.0000634
Gnomad4 AMR exome
AF:
0.0000835
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.000780
Gnomad4 SAS exome
AF:
0.0000884
Gnomad4 FIN exome
AF:
0.0000405
Gnomad4 NFE exome
AF:
0.0000326
Gnomad4 OTH exome
AF:
0.0000173
GnomAD4 genome
AF:
0.0000525
AC:
8
AN:
152298
Hom.:
0
Cov.:
32
AF XY:
0.0000537
AC XY:
4
AN XY:
74466
show subpopulations
Gnomad4 AFR
AF:
0.0000722
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000588
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000604
ExAC
AF:
0.0000388
AC:
4

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Familial hypokalemia-hypomagnesemia Pathogenic:4
Pathogenic, criteria provided, single submitterclinical testingRevvity Omics, RevvityJun 17, 2022- -
Pathogenic, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsMar 01, 2022- -
Pathogenic, criteria provided, single submitterclinical testing3billionMay 22, 2022The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.012%). Missense changes are a common disease-causing mechanism. In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.53; 3Cnet: 1.00). Same nucleotide change resulting in same amino acid change has been previously reported to be associated with SLC12A3 related disorder (ClinVar ID: VCV000944812 / PMID: 10561140). The variant has been reported to be in trans with a pathogenic variant as either compound heterozygous or homozygous in at least 2 similarly affected unrelated individuals (PMID: 10561140, 15069170, 16370563). The variant has been reported to co-segregate with the disease in at least one similarly affected relative/individual in the same family or similarly affected unrelated family (PMID: 15069170). Different missense changes at the same codon (p.Arg642Gly, p.Arg642His) have been reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000319909, VCV000397523). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. -
Pathogenic, no assertion criteria providedclinical testingNatera, Inc.Apr 02, 2020- -
not provided Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingInvitaeJan 29, 2024This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 642 of the SLC12A3 protein (p.Arg642Cys). This variant is present in population databases (rs200697179, gnomAD 0.07%). This missense change has been observed in individual(s) with Gitelman syndrome (PMID: 10561140, 15069170, 16370563, 21051746). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. This variant is also known as c.1930C>T. ClinVar contains an entry for this variant (Variation ID: 944812). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. This variant disrupts the p.Arg642 amino acid residue in SLC12A3. Other variant(s) that disrupt this residue have been observed in individuals with SLC12A3-related conditions (PMID: 12112667), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.70
BayesDel_addAF
Pathogenic
0.30
D
BayesDel_noAF
Pathogenic
0.55
Cadd
Pathogenic
35
Dann
Pathogenic
1.0
Eigen
Pathogenic
0.92
Eigen_PC
Pathogenic
0.81
FATHMM_MKL
Uncertain
0.89
D
LIST_S2
Pathogenic
0.99
D;D;D;D
M_CAP
Uncertain
0.27
D
MetaRNN
Pathogenic
0.86
D;D;D;D
MetaSVM
Uncertain
0.35
D
MutationTaster
Benign
1.0
D;D;D;D
PrimateAI
Uncertain
0.77
T
PROVEAN
Pathogenic
-7.7
D;D;D;D
Sift
Pathogenic
0.0
D;D;D;D
Sift4G
Pathogenic
0.0010
D;D;D;D
Polyphen
1.0
D;D;D;.
Vest4
0.95
MVP
0.99
MPC
0.55
ClinPred
0.99
D
GERP RS
4.4
Varity_R
0.84
gMVP
0.96

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
0.99
dbscSNV1_RF
Pathogenic
0.88
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs200697179; hg19: chr16-56919275; COSMIC: COSV52635909; API